Developer docs
API playgroundTry for free, no card

Search company profiles

Eurofins Genomics

Full company profile

uuid000d645

Namestring
Eurofins Genomics
Legal namestring
Eurofins Genomics LLC
Company typeenum
Private
Founded yearint
1988
Descriptiontext

Eurofins Genomics is a US-based subsidiary of Eurofins Scientific (Euronext Paris: ERF) operating as a global provider of DNA/RNA synthesis and sequencing services, formerly known as Operon and founded in 1988. The company runs three integrated technology pillars: DNA/RNA oligonucleotide synthesis (including the proprietary EXTREmer long-oligo platform with >99.5% coupling efficiency and 0.03-0.09% error rates, plus Express Oligos for same-day/next-day delivery), Sanger and Oxford Nanopore sequencing services, and gene synthesis (including the Blue Heron subsidiary for fragments up to 30kb and IVT mRNA). Supporting offerings include NGS panels (INVIEW packages, NGSelect semi-custom workflows, GATCLiquid Oncopanel), qPCR probes (MGB, LNA, molecular beacons), CRISPR oligos, cGMP/GMP/GLP-compliant regulated services, clinical CAP/CLIA-validated WGS, and the GENEius codon-optimization software built on the Kazusa Codon Usage Database. Manufacturing is concentrated at a Louisville, KY production facility sited adjacent to the UPS hub for expedited North American logistics, with Canadian operations in Toronto and parent-group regional entities across Europe, India, and Japan. Certifications include ISO 9001, ISO 13485, cGMP, and GLP.

The commercial model is primarily direct-to-consumer e-commerce with mandatory account creation, 24/7 online ordering, a sequencing dashboard, and transactional per-base and per-sample pricing (e.g., $0.95/base for EXTREmer oligos, $5.30/sample for fragment analysis, $15/sample for AAV sequencing, $30/sample for premium PCR sequencing). Enterprise and pharma clients access custom quotes, blanket purchase orders, and an eProcurement B2B integration. Prepaid instruments include SimpleSeq kits (96 prepaid reactions, 3-year validity), Nanocoins credits, and EVOCARD prepay cards. Customer segmentation is horizontal, spanning academic researchers (primary, 35+ year relationship base), pharma and biotech (primary, driven by regulated GLP/GMP demand), and secondary verticals of molecular diagnostics, agro science, clinical, life sciences, infectious disease, and synthetic biology.

Eurofins Genomics generates revenue not disclosed at the subsidiary level, but the combination of commodity pricing, high-throughput manufacturing, GMP/GLP-certified facilities, global delivery footprint, and a 35+ year brand position supports an estimated $100M-$250M revenue band (low confidence). The company monetizes through five primary revenue streams: oligonucleotide sales, sequencing services, gene synthesis, prepaid sequencing kits, and regulated GLP/GMP services, with technology partnerships (Agilent SureSelect, QIAGEN Ingenuity, NimbleGen SeqCap EZ, Blue Heron) extending capabilities rather than driving direct revenue capture.

Short descriptiontext

Eurofins Genomics is a US subsidiary of Eurofins Scientific providing DNA/RNA oligonucleotide synthesis, Sanger and Nanopore sequencing, gene synthesis, and NGS services to academic researchers, pharmaceutical companies, and biotech firms globally through direct e-commerce and regulated GMP/GLP workflows.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
251–500
akta.pro rankint
HeadquartersHuntsville, United States
HQ citystring
Huntsville
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
custom DNA oligonucleotide synthesis, Sanger sequencing services, gene synthesis services, Nanopore sequencing, next-generation sequencing services
Industry5 codes
1Molecular Biology & Genomics Instruments (PCR/qPCR, Sequencing, Microarrays)
CodeHLAGAIAFPrimaryYes
2mRNA & Nucleic Acid Manufacturing Services (mRNA/saRNA/Plasmid DNA)
CodeHLAGAGACPrimaryNo
3Plasmid DNA & mRNA Manufacturing Services
CodeHLAAAKAEPrimaryNo
4Transcriptomics & Gene Expression Profiling Services
CodeHLAGANAEPrimaryNo
5Molecular Diagnostics & Genomics Laboratories
CodeHLAFAMAEPrimaryNo
NAICS code4 codes
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
  • Scientific Research and Development Services5417
  • Medical Laboratories621511
  • Medical and Diagnostic Laboratories6215
SIC code1 code
  • Services-Commercial Physical & Biological Research8731
Product category
Genomics Services and DNA/RNA Synthesis
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model5 records
1DNA/RNA Oligonucleotide Sales
TypeOne Time License
Description

Sale of custom oligonucleotides including DNA oligos, RNA oligos, modified oligos, EXTREmers, and specialty probes (qPCR, MGB, LNA). Products sold per-base pricing with various purification options and scales.

eurofinsgenomics.com
2Sequencing Services
TypeTransaction Fee
Description

Sanger sequencing, Nanopore sequencing, and NGS services offered as fee-for-service with various turnaround times (overnight, express, standard). Includes prepaid kits and per-reaction pricing.

eurofinsgenomics.com
3Gene Synthesis
TypeTransaction Fee
Description

Gene synthesis services delivering double-stranded DNA constructs in plasmids, including GeneStrands (fragments) and full genes up to 30kb. Express service available for faster delivery.

eurofinsgenomics.com
4Prepaid Sequencing Kits
TypeOne Time License
Description

SimpleSeq kits and prepaid plates offering 96 prepaid sequencing reactions with 3-year validity. One-time purchase model with redemption online only.

eurofinsgenomics.com
5Regulatory/GLP/GMP Services
TypeProfessional Services
Description

Good Laboratory Practice (GLP) and Good Manufacturing Practice (GMP) sequencing for regulatory compliance, pharmaceutical, and clinical applications requiring documented quality control and traceability.

eurofinsgenomics.com
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Technology or R&D, Supply Chain, Infrastructure, Marketing or Sales
Pricing details7 tiers
1EXTREmer Oligos 4nmole salt-free tubes at $0.95/base vs competitor $0.99/base
ModelUnit PricingBilling cadencePay-as-you-go
Notes

4 nmole yield salt-free in tubes: $0.95/base. 4 nmole yield salt-free in plates: $0.50/base. 25 nmole salt-free tubes: $1.95/base. 25 nmole salt-free plates: $1.05/base. Price includes quality control by ESI-MS or CGE.

eurofinsgenomics.com
2Fragment Analysis at $5.30/sample with no minimum sample requirement per plate
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Fragment Analysis Ready2Load service: $5.30/sample. No project too small, no challenge too big. Billed per sample.

eurofinsgenomics.com
3Premium PCR Sequencing starting at $30/sample using ligation-based Nanopore sequencing
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Premium PCR Sequencing: as low as $30/sample. Ligation-based sequencing, no fragmentation, perfect for small amplicons and mixtures.

eurofinsgenomics.com
4Gene Fragments with 50% price drop promotion
ModelUnit PricingBilling cadencePay-as-you-go
Notes

50% price drop on GeneStrands (gene fragments). Same research at half the cost.

eurofinsgenomics.com
5Express Oligos (5-40 bases) free surcharge for tubes, $45/plate for plates
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Express Oligos in tubes: Free surcharge, cut-off 5pm ET, delivered next day. Express Plates: $45/plate surcharge, cut-off 3pm ET, delivered 1-2 days. Restrictions apply on length (5-40 bases), scale (10-25nmole), and purification (salt-free only).

eurofinsgenomics.com
6AAV Sequencing starting at $15/sample for Oxford Nanopore Technology
ModelUnit PricingBilling cadencePay-as-you-go
Notes

AAV Sequencing now available for ONT Sequencing, starting at only $15/sample.

eurofinsgenomics.com
7SimpleSeq Kits with 96 prepaid reactions
ModelUnit PricingBilling cadenceMulti-year contract
Notes

SimpleSeq kits include purchase of 96 prepaid sequencing reactions with 2D bar-coded tubes for template submission. Tubes remaining after all prepaid reactions can be used to purchase additional reactions at prepaid price. 3-year expiration on prepaid reactions.

eurofinsgenomics.com
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 record
1Blue Heron
Description

Premium gene synthesis services including IVT mRNA synthesis products and services, ordered directly from Blue Heron website

eurofinsgenomics.com
Core offering1 text field

Eurofins Genomics manufactures and sells custom DNA/RNA oligonucleotides (including EXTREmer long oligos, qPCR/MGB/LNA probes, NGS oligos, and cGMP oligos) and provides fee-for-service DNA sequencing services (Sanger, Nanopore/Oxford Nanopore, and Next-Generation Sequencing) along with gene synthesis of double-stranded DNA constructs up to 30kb. The offering is positioned as a complete "reading and writing" DNA platform for academic researchers, pharmaceutical and biotech companies, clinical labs, and molecular diagnostics developers, with a US production facility co-located with the UPS hub for fastest delivery.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 6 values shown
  • >90% of standard desalted orders shipped within 24 hours
+5 more records
Product overview1 text field

Eurofins Genomics operates as a comprehensive genomics services platform offering three core technology pillars: DNA/RNA synthesis (reading DNA via sequencing services and writing DNA via oligonucleotide and gene synthesis). The product portfolio spans Custom DNA/RNA Oligonucleotides and EXTREmer Long Oligos for synthesis, Sanger and Nanopore Sequencing for reading DNA, and Gene Synthesis/GeneStrands for double-stranded DNA production. Supporting services include qPCR Probes, CRISPR Products, cGMP Oligos for regulated environments, and extensive Next Generation Sequencing offerings including Clinical WGS, INVIEW pre-designed packages, NGSelect semi-custom panels, and GATCLiquid oncology panels. Additional offerings comprise bioinformatics solutions (De Novo Assembly, BLAST Analysis, variant analysis), genotyping services, cell line authentication, and specialty products like SalivaDirect and ARTIC primers. The company also provides prepayment systems (Nanocoins, EVOCARD), sequencing kits (SimpleSeq), and the proprietary GENEius optimization software for gene design.

Product and service41 records
1Custom DNA/RNA Oligonucleotides
CategoryDNA/RNA Synthesis
Description

Single-stranded DNA and RNA oligonucleotide synthesis services producing short custom sequences (5-125 bases) for research applications including PCR, cloning, and diagnostics. Over 90% of standard desalted orders are shipped within 24 hours with quality checked by ESI-MS.

2Express Oligos
CategoryDNA/RNA Synthesis
Description

Expedited oligo synthesis service delivering primers in 1 day with same-day shipping, featuring proprietary high-efficiency synthesis technology and US production facility location near UPS hub. Supports tubes and plates with cut-off times of 5pm ET (tubes) and 3pm ET (plates).

3EXTREmer Long Oligos
CategoryDNA/RNA Synthesis
Description

High-quality long oligonucleotide synthesis (60-200 bases) with low error rates (0.03-0.09%), >99.5% coupling efficiency, suitable for gene synthesis, cloning, CRISPR, and synthetic biology applications. Demonstrated up to 71% good clones in representative studies versus 14% with competitor oligos.

4qPCR Probes
CategoryDNA/RNA Synthesis
Description

Quantitative PCR probes including standard dual-label probes, MGB (Minor Groove Binder) probes, LNA (Locked Nucleic Acid) probes, and Molecular Beacons delivered in 3-5 business days for qPCR assay development.

5MGB Probes
CategoryDNA/RNA Synthesis
Description

Minor Groove Binder probes offering enhanced hybridization properties for qPCR assays with improved specificity and thermal stability.

6LNA Probes
CategoryDNA/RNA Synthesis
Description

Locked Nucleic Acid probes with increased affinity and specificity for target sequences in qPCR applications.

7NGS Oligos and Adapters
CategoryDNA/RNA Synthesis
Description

Next-generation sequencing oligos including UMIs, barcoded adapters, target enrichment probes, and NGS grade oligos for library preparation applications.

8cGMP Oligonucleotides
CategoryDNA/RNA Synthesis
Description

cGMP-manufactured oligos for clinical and diagnostic applications, IVD production, and ASR (Analyte Specific Reagent) manufacturing compliant with regulatory requirements. Manufactured in the US cGMP facility.

9CRISPR Products
CategoryDNA/RNA Synthesis
Description

CRISPR/Cas9 genome editing products including oligos and gene fragments optimized for CRISPR applications using EXTREmer technology.

10Sanger Sequencing Service
CategoryDNA Sequencing Services
Description

Gold-standard DNA sequencing service including standard tube sequencing, overnight sequencing, high-volume plate sequencing, and premium read options with free barcodes and digital shipping labels. 99% of tube results arrive the next morning.

11SimpleSeq Kits
CategoryDNA Sequencing Services
Description

Prepaid sequencing kits containing 96 barcoded 2D tubes for convenient sample submission with built-in primer storage, tracking dashboard, and 3-year validity.

12GLP Sequencing
CategoryDNA Sequencing Services
Description

Good Laboratory Practice compliant sequencing service for regulatory and preclinical studies with full documentation and traceability.

13GMP Sequencing
CategoryDNA Sequencing Services
Description

Good Manufacturing Practice compliant sequencing for regulated environments requiring highest quality control and documentation standards.

14Nanopore Sequencing
CategoryDNA Sequencing Services
Description

Oxford Nanopore Technology-based long-read sequencing for whole plasmids, linear amplicons, bacterial genomes, and AAV vectors with fast turnaround and $15/sample starting price.

15Nanocoins
CategoryDNA Sequencing Services
Description

Prepaid credit system for Nanopore sequencing allowing flexible access to sequencing services with account-based tracking.

16Gene Synthesis
CategoryGene Synthesis
Description

Double-stranded DNA gene synthesis service producing sequences from short simple constructs to 30kb complex genes in expression-ready vectors.

17Express Genes
CategoryGene Synthesis
Description

Expedited gene synthesis service with accelerated turnaround time for genes manufactured in the USA.

18GeneStrands Fragments
CategoryGene Synthesis
Description

Low-error linear double-stranded DNA fragments up to 3000bp for gene assembly, cloning, and CRISPR applications with 50% price promotion available.

19Plasmid Prep
CategoryGene Synthesis
Description

Plasmid DNA preparation service in midi, maxi, and giga scales for researchers needing scaled-up plasmid quantities.

20IVT mRNA
CategoryGene Synthesis
Description

In-vitro transcription mRNA synthesis products and services for vaccine and therapeutic research applications, offered via Blue Heron.

21Clinical Whole Genome Sequencing (30X)
CategoryNext-Generation Sequencing
Description

CAP/CLIA validated whole genome sequencing service using Illumina NovaSeq X Plus and NovaSeq 6000 platforms for clinical research.

22INVIEW Packages
CategoryNext-Generation Sequencing
Description

Pre-designed NGS packages including INVIEW Genome, Microbiome, Transcriptome, Metagenome, Exome, and Panel options optimized for common applications.

23NGSelect
CategoryNext-Generation Sequencing
Description

Semi-customizable NGS options including NGSelect DNA, RNA, Amplicon, and Ready2Load for tailored sequencing projects.

24GATCLiquid Oncopanel All-in-one
CategoryNext-Generation Sequencing
Description

Liquid biopsy cancer panel detecting mutations in 597 cancer-associated genes from cell-free DNA using hybrid capture and Illumina sequencing with 1% allele frequency detection limit.

25GATCLiquid Oncoexome
CategoryNext-Generation Sequencing
Description

Whole exome sequencing service for liquid biopsy samples targeting cancer-relevant genomic regions for comprehensive mutation profiling.

26Custom Genome Sequencing
CategoryNext-Generation Sequencing
Description

Fully custom NGS solutions for genome sequencing projects with tailored sample preparation and analysis workflows.

27Transcriptome Sequencing
CategoryNext-Generation Sequencing
Description

RNA sequencing services including de novo transcriptome, expression profiling, and small RNA sequencing using Illumina platforms.

28Expression Profiling
CategoryNext-Generation Sequencing
Description

mRNA-Seq based gene expression analysis service detecting alternative splice sites, fusion genes, and comprehensive transcriptome coverage.

29Small RNA Sequencing
CategoryNext-Generation Sequencing
Description

Small RNA sequencing service for discovering novel miRNAs and analyzing small RNA expression using Illumina HiSeq 2500 and MiSeq.

30Resequencing by Sequence Capture
CategoryNext-Generation Sequencing
Description

Targeted resequencing using NimbleGen SeqCap EZ capture technology for focused analysis of specific genomic regions up to 200 Mbp, with capacity for up to 940 samples simultaneously.

31De Novo Assembly
CategoryBioinformatics
Description

Genome and transcriptome assembly service using software tools like Newbler, Celera, Mira, and Velvet for reconstructing sequences without reference genomes.

32Bioinformatic Solutions
CategoryBioinformatics
Description

Comprehensive bioinformatics services including de novo assembly, mapping, variance analysis, transcriptome analysis, amplicon variance analysis, and BLAST against latest databases.

33BLAST Analysis
CategoryBioinformatics
Description

High-speed BLAST sequence similarity search service against public or custom databases for functional annotation and sequence comparison.

3416S Microbiome Profiling
CategoryNext-Generation Sequencing
Description

Bacterial analysis service using 16S rRNA gene sequencing, available as CAP/CLIA validated option for clinical microbiome studies.

35Clinical Microarrays
CategoryNext-Generation Sequencing
Description

CAP/CLIA validated genotyping microarray service with 654,027 fixed markers for high-throughput genetic analysis.

36GenoTyping Services
CategoryApplied Genomics
Description

Genetic variation analysis services including SNP genotyping, microsatellites, human identification, and GWAS studies.

37Cell Line Authentication
CategoryApplied Genomics
Description

Authentication service for verifying cell line identity and detecting contamination using genetic methods.

38Fragment Analysis Ready2Load
CategoryDNA Sequencing Services
Description

Fragment analysis service for pre-cycled samples at $5.30/sample with no minimum sample requirement for plate submissions.

39ARTIC Primers
CategoryDNA/RNA Synthesis
Description

ARTIC primer pools for viral sequencing, originally developed for SARS-CoV-2 but applicable to other viruses.

40SalivaDirect Kits
CategoryDiagnostic Products
Description

Saliva-based molecular diagnostic testing kits for non-invasive sample collection.

41EVOCARD Prepay Cards
CategoryPayment Instruments
Description

Prepaid payment cards for funding genomics services with online ordering and automatic deduction for sequencing and oligo orders.

Scale indicator8 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
Strategic tierCoreTypeTechnology or Integration
Description

Eurofins Genomics uses Agilent SureSelect chemistry for GATCLiquid Oncopanel All-in-one cancer gene panel testing. The service utilizes hybridization-based target capture with proprietary protocols and latest Agilent SureSelect technology for cfDNA analysis of 597 cancer-relevant genes.

2NimbleGen (SeqCap EZ)
Strategic tierCoreTypeTechnology or Integration
Description

Eurofins together with NimbleGen offers sequence capture with NimbleGen EZ Libraries for customized capture projects. NimbleGen's 50-105-mer probes with special design algorithms provide higher uniformed coverage than other methods for targeted resequencing. Available layouts include SeqCap EZ Choice (up to 7 Mbp), EZ Choice XL (up to 200 Mbp), and EZ Developer (up to 200 Mbp).

eurofinsgenomics.com
3Blue Heron (IVT mRNA, Gene Synthesis)
Strategic tierCoreTypeTechnology or Integration
Description

Blue Heron genes and IVT mRNA services are available through Eurofins Genomics. Blue Heron provides specialized gene synthesis capabilities and IVT mRNA synthesis services, accessible via redirect ordering from the Eurofins website.

eurofinsgenomics.com
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

GenScript is a global gene synthesis and oligo/peptide provider with overlapping gene synthesis, oligo, IVT mRNA, and protein offerings; comparable in scale, customer base (academic + pharma), and competitive pricing pressure on Eurofins' GeneStrands and gene products.

TypeDirect peer
Description

Synthego competes in synthetic biology and CRISPR-focused oligo and gene editing products, overlapping with Eurofins' EXTREmer and CRISPR product lines for academic and biotech synthetic biology customers.

TypeDirect peer
Description

IDT is the most directly comparable custom oligonucleotide and gene synthesis provider (now part of Danaher), competing head-to-head on custom oligos, qPCR probes, Sanger/NGS services, and gene synthesis for the same academic, pharma, and diagnostics customers.

TypeBroad incumbent
Description

Agilent is both a partner (SureSelect target capture) and a competitor in genomics services, NGS, oligo/CGH arrays, and molecular diagnostics; comparable in pharma/biotech and clinical customer overlap.

TypeBroad incumbent
Description

Thermo Fisher competes across oligos, Sanger/NGS sequencing services, qPCR, gene synthesis, and clinical genomics via brands such as Invitrogen and GeneArt; a broader incumbent whose portfolio overlaps with most of Eurofins Genomics' offerings.

TypeBroad incumbent
Description

Bio-Rad offers molecular biology tools, qPCR/dPCR systems, and reagents that intersect with Eurofins' oligo and qPCR probe offerings for academic and clinical research customers.

TypeBroad incumbent
Description

QIAGEN competes in sample preparation, NGS panels, and bioinformatics (Ingenuity Variant Analysis) for molecular diagnostics and life science research customers, and is also a partner to Eurofins in the GATCLiquid Oncopanel workflow.

TypeDirect peer
Description

Twist is a direct competitor in DNA synthesis using a silicon platform, with strengths in oligo pools, gene fragments, and NGS target enrichment — directly addressing the same synthetic biology, NGS, and gene synthesis buyers as Eurofins Genomics.

TypeDirect peer
Description

LGC Biosearch Technologies is a direct oligo and genomics services peer (custom oligos, probes, NGS services, PCR reagents), competing for the same academic, agbio, and diagnostic customers as Eurofins Genomics.

TypeRegional player
Description

Bioneer is an Asia-based (Korea) oligo synthesis and molecular diagnostics provider with comparable custom oligo and gene synthesis offerings, primarily serving Asia-Pacific customers in geographic markets where Eurofins Genomics has regional sites.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers9 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment8 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration4 records

Each record includes

Title, Type, Description, Source

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance4 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Eurofins Genomics

Genomics Services and DNA/RNA Synthesiseurofinsgenomics.com

Eurofins Genomics is a US subsidiary of Eurofins Scientific providing DNA/RNA oligonucleotide synthesis, Sanger and Nanopore sequencing, gene synthesis, and NGS services to academic researchers, pharmaceutical companies, and biotech firms globally through direct e-commerce and regulated GMP/GLP workflows.

What Eurofins Genomics does

Eurofins Genomics is a US-based subsidiary of Eurofins Scientific (Euronext Paris: ERF) operating as a global provider of DNA/RNA synthesis and sequencing services, formerly known as Operon and founded in 1988. The company runs three integrated technology pillars: DNA/RNA oligonucleotide synthesis (including the proprietary EXTREmer long-oligo platform with >99.5% coupling efficiency and 0.03-0.09% error rates, plus Express Oligos for same-day/next-day delivery), Sanger and Oxford Nanopore sequencing services, and gene synthesis (including the Blue Heron subsidiary for fragments up to 30kb and IVT mRNA). Supporting offerings include NGS panels (INVIEW packages, NGSelect semi-custom workflows, GATCLiquid Oncopanel), qPCR probes (MGB, LNA, molecular beacons), CRISPR oligos, cGMP/GMP/GLP-compliant regulated services, clinical CAP/CLIA-validated WGS, and the GENEius codon-optimization software built on the Kazusa Codon Usage Database. Manufacturing is concentrated at a Louisville, KY production facility sited adjacent to the UPS hub for expedited North American logistics, with Canadian operations in Toronto and parent-group regional entities across Europe, India, and Japan. Certifications include ISO 9001, ISO 13485, cGMP, and GLP.

The commercial model is primarily direct-to-consumer e-commerce with mandatory account creation, 24/7 online ordering, a sequencing dashboard, and transactional per-base and per-sample pricing (e.g., $0.95/base for EXTREmer oligos, $5.30/sample for fragment analysis, $15/sample for AAV sequencing, $30/sample for premium PCR sequencing). Enterprise and pharma clients access custom quotes, blanket purchase orders, and an eProcurement B2B integration. Prepaid instruments include SimpleSeq kits (96 prepaid reactions, 3-year validity), Nanocoins credits, and EVOCARD prepay cards. Customer segmentation is horizontal, spanning academic researchers (primary, 35+ year relationship base), pharma and biotech (primary, driven by regulated GLP/GMP demand), and secondary verticals of molecular diagnostics, agro science, clinical, life sciences, infectious disease, and synthetic biology.

Eurofins Genomics generates revenue not disclosed at the subsidiary level, but the combination of commodity pricing, high-throughput manufacturing, GMP/GLP-certified facilities, global delivery footprint, and a 35+ year brand position supports an estimated $100M-$250M revenue band (low confidence). The company monetizes through five primary revenue streams: oligonucleotide sales, sequencing services, gene synthesis, prepaid sequencing kits, and regulated GLP/GMP services, with technology partnerships (Agilent SureSelect, QIAGEN Ingenuity, NimbleGen SeqCap EZ, Blue Heron) extending capabilities rather than driving direct revenue capture.

Eurofins Genomics firmographics

Firmographics
Name
Eurofins Genomics
Legal name
Eurofins Genomics LLC
Website
https://eurofinsgenomics.com
Company type
Private
Founded year
1988
Operating status
Operating
Headcount range
251–500 employees
Short description
Eurofins Genomics is a US subsidiary of Eurofins Scientific providing DNA/RNA oligonucleotide synthesis, Sanger and Nanopore sequencing, gene synthesis, and NGS services to academic researchers, pharmaceutical companies, and biotech firms globally through direct e-commerce and regulated GMP/GLP workflows.
Ownership category
akta.pro rank

Eurofins Genomics industry classification

Industry
Product category
Genomics Services and DNA/RNA Synthesis
NAICS
Research and Development in Biotechnology (except Nanobiotechnology) (541714), Scientific Research and Development Services (5417), Medical Laboratories (621511), Medical and Diagnostic Laboratories (6215)
SIC
Services-Commercial Physical & Biological Research (8731)
akta.pro primary industry
Molecular Biology & Genomics Instruments (PCR/qPCR, Sequencing, Microarrays) (HLAGAIAF)
akta.pro secondary industries
mRNA & Nucleic Acid Manufacturing Services (mRNA/saRNA/Plasmid DNA) (HLAGAGAC), Plasmid DNA & mRNA Manufacturing Services (HLAAAKAE), Transcriptomics & Gene Expression Profiling Services (HLAGANAE), Molecular Diagnostics & Genomics Laboratories (HLAFAMAE)

Keywords

  • Custom DNA oligonucleotide synthesis
  • Sanger sequencing services
  • Gene synthesis services
  • Nanopore sequencing
  • Next-generation sequencing services

Where Eurofins Genomics is headquartered

Location

Headquarters

HQ city
Huntsville
HQ country
United States
HQ region
North America

Offices3 records

Markets served

Eurofins Genomics business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Supply Chain, Infrastructure, Marketing or Sales

Revenue model

  1. DNA/RNA Oligonucleotide Sales: Sale of custom oligonucleotides including DNA oligos, RNA oligos, modified oligos, EXTREmers, and specialty probes (qPCR, MGB, LNA). Products sold per-base pricing with various purification options and scales.
  2. Sequencing Services: Sanger sequencing, Nanopore sequencing, and NGS services offered as fee-for-service with various turnaround times (overnight, express, standard). Includes prepaid kits and per-reaction pricing.
  3. Gene Synthesis: Gene synthesis services delivering double-stranded DNA constructs in plasmids, including GeneStrands (fragments) and full genes up to 30kb. Express service available for faster delivery.
  4. Prepaid Sequencing Kits: SimpleSeq kits and prepaid plates offering 96 prepaid sequencing reactions with 3-year validity. One-time purchase model with redemption online only.
  5. Regulatory/GLP/GMP Services: Good Laboratory Practice (GLP) and Good Manufacturing Practice (GMP) sequencing for regulatory compliance, pharmaceutical, and clinical applications requiring documented quality control and traceability.

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goEXTREmer Oligos 4nmole salt-free tubes at $0.95/base vs competitor $0.99/base
Unit PricingPay-as-you-goFragment Analysis at $5.30/sample with no minimum sample requirement per plate
Unit PricingPay-as-you-goPremium PCR Sequencing starting at $30/sample using ligation-based Nanopore sequencing
Unit PricingPay-as-you-goGene Fragments with 50% price drop promotion
Unit PricingPay-as-you-goExpress Oligos (5-40 bases) free surcharge for tubes, $45/plate for plates
Unit PricingPay-as-you-goAAV Sequencing starting at $15/sample for Oxford Nanopore Technology
Unit PricingMulti-year contractSimpleSeq Kits with 96 prepaid reactions

Go-to-market motion1 record

Distribution channels5 records

Marketing channels8 records

Eurofins Genomics product offering

Product offering

Core offering

Eurofins Genomics manufactures and sells custom DNA/RNA oligonucleotides (including EXTREmer long oligos, qPCR/MGB/LNA probes, NGS oligos, and cGMP oligos) and provides fee-for-service DNA sequencing services (Sanger, Nanopore/Oxford Nanopore, and Next-Generation Sequencing) along with gene synthesis of double-stranded DNA constructs up to 30kb. The offering is positioned as a complete "reading and writing" DNA platform for academic researchers, pharmaceutical and biotech companies, clinical labs, and molecular diagnostics developers, with a US production facility co-located with the UPS hub for fastest delivery.

Product overview

Eurofins Genomics operates as a comprehensive genomics services platform offering three core technology pillars: DNA/RNA synthesis (reading DNA via sequencing services and writing DNA via oligonucleotide and gene synthesis). The product portfolio spans Custom DNA/RNA Oligonucleotides and EXTREmer Long Oligos for synthesis, Sanger and Nanopore Sequencing for reading DNA, and Gene Synthesis/GeneStrands for double-stranded DNA production. Supporting services include qPCR Probes, CRISPR Products, cGMP Oligos for regulated environments, and extensive Next Generation Sequencing offerings including Clinical WGS, INVIEW pre-designed packages, NGSelect semi-custom panels, and GATCLiquid oncology panels. Additional offerings comprise bioinformatics solutions (De Novo Assembly, BLAST Analysis, variant analysis), genotyping services, cell line authentication, and specialty products like SalivaDirect and ARTIC primers. The company also provides prepayment systems (Nanocoins, EVOCARD), sequencing kits (SimpleSeq), and the proprietary GENEius optimization software for gene design.

Differentiator

Problem solved

Functional benefit

Brands

  • Blue Heron: Premium gene synthesis services including IVT mRNA synthesis products and services, ordered directly from Blue Heron website

Products and services

  • Custom DNA/RNA Oligonucleotides Single-stranded DNA and RNA oligonucleotide synthesis services producing short custom sequences (5-125 bases) for research applications including PCR, cloning, and diagnostics. Over 90% of standard desalted orders are shipped within 24 hours with quality checked by ESI-MS.
  • Express Oligos Expedited oligo synthesis service delivering primers in 1 day with same-day shipping, featuring proprietary high-efficiency synthesis technology and US production facility location near UPS hub. Supports tubes and plates with cut-off times of 5pm ET (tubes) and 3pm ET (plates).
  • EXTREmer Long Oligos High-quality long oligonucleotide synthesis (60-200 bases) with low error rates (0.03-0.09%), >99.5% coupling efficiency, suitable for gene synthesis, cloning, CRISPR, and synthetic biology applications. Demonstrated up to 71% good clones in representative studies versus 14% with competitor oligos.
  • qPCR Probes Quantitative PCR probes including standard dual-label probes, MGB (Minor Groove Binder) probes, LNA (Locked Nucleic Acid) probes, and Molecular Beacons delivered in 3-5 business days for qPCR assay development.
  • MGB Probes Minor Groove Binder probes offering enhanced hybridization properties for qPCR assays with improved specificity and thermal stability.
  • LNA Probes Locked Nucleic Acid probes with increased affinity and specificity for target sequences in qPCR applications.
  • NGS Oligos and Adapters Next-generation sequencing oligos including UMIs, barcoded adapters, target enrichment probes, and NGS grade oligos for library preparation applications.
  • cGMP Oligonucleotides cGMP-manufactured oligos for clinical and diagnostic applications, IVD production, and ASR (Analyte Specific Reagent) manufacturing compliant with regulatory requirements. Manufactured in the US cGMP facility.
  • CRISPR Products CRISPR/Cas9 genome editing products including oligos and gene fragments optimized for CRISPR applications using EXTREmer technology.
  • Sanger Sequencing Service Gold-standard DNA sequencing service including standard tube sequencing, overnight sequencing, high-volume plate sequencing, and premium read options with free barcodes and digital shipping labels. 99% of tube results arrive the next morning.
  • SimpleSeq Kits Prepaid sequencing kits containing 96 barcoded 2D tubes for convenient sample submission with built-in primer storage, tracking dashboard, and 3-year validity.
  • GLP Sequencing Good Laboratory Practice compliant sequencing service for regulatory and preclinical studies with full documentation and traceability.
  • GMP Sequencing Good Manufacturing Practice compliant sequencing for regulated environments requiring highest quality control and documentation standards.
  • Nanopore Sequencing Oxford Nanopore Technology-based long-read sequencing for whole plasmids, linear amplicons, bacterial genomes, and AAV vectors with fast turnaround and $15/sample starting price.
  • Nanocoins Prepaid credit system for Nanopore sequencing allowing flexible access to sequencing services with account-based tracking.
  • Gene Synthesis Double-stranded DNA gene synthesis service producing sequences from short simple constructs to 30kb complex genes in expression-ready vectors.
  • Express Genes Expedited gene synthesis service with accelerated turnaround time for genes manufactured in the USA.
  • GeneStrands Fragments Low-error linear double-stranded DNA fragments up to 3000bp for gene assembly, cloning, and CRISPR applications with 50% price promotion available.
  • Plasmid Prep Plasmid DNA preparation service in midi, maxi, and giga scales for researchers needing scaled-up plasmid quantities.
  • IVT mRNA In-vitro transcription mRNA synthesis products and services for vaccine and therapeutic research applications, offered via Blue Heron.
  • Clinical Whole Genome Sequencing (30X) CAP/CLIA validated whole genome sequencing service using Illumina NovaSeq X Plus and NovaSeq 6000 platforms for clinical research.
  • INVIEW Packages Pre-designed NGS packages including INVIEW Genome, Microbiome, Transcriptome, Metagenome, Exome, and Panel options optimized for common applications.
  • NGSelect Semi-customizable NGS options including NGSelect DNA, RNA, Amplicon, and Ready2Load for tailored sequencing projects.
  • GATCLiquid Oncopanel All-in-one Liquid biopsy cancer panel detecting mutations in 597 cancer-associated genes from cell-free DNA using hybrid capture and Illumina sequencing with 1% allele frequency detection limit.
  • GATCLiquid Oncoexome Whole exome sequencing service for liquid biopsy samples targeting cancer-relevant genomic regions for comprehensive mutation profiling.
  • Custom Genome Sequencing Fully custom NGS solutions for genome sequencing projects with tailored sample preparation and analysis workflows.
  • Transcriptome Sequencing RNA sequencing services including de novo transcriptome, expression profiling, and small RNA sequencing using Illumina platforms.
  • Expression Profiling mRNA-Seq based gene expression analysis service detecting alternative splice sites, fusion genes, and comprehensive transcriptome coverage.
  • Small RNA Sequencing Small RNA sequencing service for discovering novel miRNAs and analyzing small RNA expression using Illumina HiSeq 2500 and MiSeq.
  • Resequencing by Sequence Capture Targeted resequencing using NimbleGen SeqCap EZ capture technology for focused analysis of specific genomic regions up to 200 Mbp, with capacity for up to 940 samples simultaneously.
  • De Novo Assembly Genome and transcriptome assembly service using software tools like Newbler, Celera, Mira, and Velvet for reconstructing sequences without reference genomes.
  • Bioinformatic Solutions Comprehensive bioinformatics services including de novo assembly, mapping, variance analysis, transcriptome analysis, amplicon variance analysis, and BLAST against latest databases.
  • BLAST Analysis High-speed BLAST sequence similarity search service against public or custom databases for functional annotation and sequence comparison.
  • 16S Microbiome Profiling Bacterial analysis service using 16S rRNA gene sequencing, available as CAP/CLIA validated option for clinical microbiome studies.
  • Clinical Microarrays CAP/CLIA validated genotyping microarray service with 654,027 fixed markers for high-throughput genetic analysis.
  • GenoTyping Services Genetic variation analysis services including SNP genotyping, microsatellites, human identification, and GWAS studies.
  • Cell Line Authentication Authentication service for verifying cell line identity and detecting contamination using genetic methods.
  • Fragment Analysis Ready2Load Fragment analysis service for pre-cycled samples at $5.30/sample with no minimum sample requirement for plate submissions.
  • ARTIC Primers ARTIC primer pools for viral sequencing, originally developed for SARS-CoV-2 but applicable to other viruses.
  • SalivaDirect Kits Saliva-based molecular diagnostic testing kits for non-invasive sample collection.
  • EVOCARD Prepay Cards Prepaid payment cards for funding genomics services with online ordering and automatic deduction for sequencing and oligo orders.

Quantifiable outcome

  • >90% of standard desalted orders shipped within 24 hours
  • +5 more outcomes

Companies that use Eurofins Genomics

Customer profile

Named customers9 records

Segments8 records

Ideal customer profiles4 records

Eurofins Genomics technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration4 records

Feature4 records

Eurofins Genomics partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered core.

  • Agilent (SureSelect Technology)coreTechnology or IntegrationEurofins Genomics uses Agilent SureSelect chemistry for GATCLiquid Oncopanel All-in-one cancer gene panel testing. The service utilizes hybridization-based target capture with proprietary protocols and latest Agilent SureSelect technology for cfDNA analysis of 597 cancer-relevant genes.
  • NimbleGen (SeqCap EZ)coreTechnology or IntegrationEurofins together with NimbleGen offers sequence capture with NimbleGen EZ Libraries for customized capture projects. NimbleGen's 50-105-mer probes with special design algorithms provide higher uniformed coverage than other methods for targeted resequencing. Available layouts include SeqCap EZ Choice (up to 7 Mbp), EZ Choice XL (up to 200 Mbp), and EZ Developer (up to 200 Mbp).
  • Blue Heron (IVT mRNA, Gene Synthesis)coreTechnology or IntegrationBlue Heron genes and IVT mRNA services are available through Eurofins Genomics. Blue Heron provides specialized gene synthesis capabilities and IVT mRNA synthesis services, accessible via redirect ordering from the Eurofins website.

Scale indicators8 records

Recent moves6 records

Expansion highlights6 records

Eurofins Genomics competitors and assessment

Company assessment

Direct peers

  • GenScript: GenScript is a global gene synthesis and oligo/peptide provider with overlapping gene synthesis, oligo, IVT mRNA, and protein offerings; comparable in scale, customer base (academic + pharma), and competitive pricing pressure on Eurofins' GeneStrands and gene products.
  • Synthego: Synthego competes in synthetic biology and CRISPR-focused oligo and gene editing products, overlapping with Eurofins' EXTREmer and CRISPR product lines for academic and biotech synthetic biology customers.
  • Integrated DNA Technologies (IDT): IDT is the most directly comparable custom oligonucleotide and gene synthesis provider (now part of Danaher), competing head-to-head on custom oligos, qPCR probes, Sanger/NGS services, and gene synthesis for the same academic, pharma, and diagnostics customers.
  • Twist Bioscience: Twist is a direct competitor in DNA synthesis using a silicon platform, with strengths in oligo pools, gene fragments, and NGS target enrichment — directly addressing the same synthetic biology, NGS, and gene synthesis buyers as Eurofins Genomics.
  • LGC Biosearch Technologies: LGC Biosearch Technologies is a direct oligo and genomics services peer (custom oligos, probes, NGS services, PCR reagents), competing for the same academic, agbio, and diagnostic customers as Eurofins Genomics.

Broad incumbents

  • Agilent Technologies: Agilent is both a partner (SureSelect target capture) and a competitor in genomics services, NGS, oligo/CGH arrays, and molecular diagnostics; comparable in pharma/biotech and clinical customer overlap.
  • Thermo Fisher Scientific: Thermo Fisher competes across oligos, Sanger/NGS sequencing services, qPCR, gene synthesis, and clinical genomics via brands such as Invitrogen and GeneArt; a broader incumbent whose portfolio overlaps with most of Eurofins Genomics' offerings.
  • Bio-Rad Laboratories: Bio-Rad offers molecular biology tools, qPCR/dPCR systems, and reagents that intersect with Eurofins' oligo and qPCR probe offerings for academic and clinical research customers.
  • QIAGEN: QIAGEN competes in sample preparation, NGS panels, and bioinformatics (Ingenuity Variant Analysis) for molecular diagnostics and life science research customers, and is also a partner to Eurofins in the GATCLiquid Oncopanel workflow.

Regional players

  • Bioneer: Bioneer is an Asia-based (Korea) oligo synthesis and molecular diagnostics provider with comparable custom oligo and gene synthesis offerings, primarily serving Asia-Pacific customers in geographic markets where Eurofins Genomics has regional sites.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

Eurofins Genomics social profiles

Digital presence

Eurofins Genomics compliance and trust

Trust signal

Compliance4 records

Eurofins Genomics financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Eurofins Genomics leadership team

Management profile

Number of profiles

Eurofins Genomics subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

Eurofins Genomics funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Eurofins Genomics M&A and investment

M&A and investment

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Eurofins Genomics

What does Eurofins Genomics do?

Eurofins Genomics manufactures and sells custom DNA/RNA oligonucleotides (including EXTREmer long oligos, qPCR/MGB/LNA probes, NGS oligos, and cGMP oligos) and provides fee-for-service DNA sequencing services (Sanger, Nanopore/Oxford Nanopore, and Next-Generation Sequencing) along with gene synthesis of double-stranded DNA constructs up to 30kb. The offering is positioned as a complete "reading and writing" DNA platform for academic researchers, pharmaceutical and biotech companies, clinical labs, and molecular diagnostics developers, with a US production facility co-located with the UPS hub for fastest delivery.

Is Eurofins Genomics a public or private company?

Eurofins Genomics is a private company. It is classified as corporate owned and is currently operating.

When was Eurofins Genomics founded?

Eurofins Genomics was founded in 1988. It employs 251 to 500 people.

Where is Eurofins Genomics based?

Eurofins Genomics is headquartered in Huntsville, United States, in the North America region.

How does Eurofins Genomics make money?

Five revenue lines are on record. DNA/RNA Oligonucleotide Sales are the primary driver. The others are sequencing Services, gene Synthesis, prepaid Sequencing Kits and regulatory/GLP/GMP Services.

Who are Eurofins Genomics's main competitors?

Direct peers on record are GenScript, Synthego, Integrated DNA Technologies (IDT), Twist Bioscience and LGC Biosearch Technologies. Broad incumbents are Agilent Technologies, Thermo Fisher Scientific, Bio-Rad Laboratories and QIAGEN. Bioneer is listed as a regional player.

Does Eurofins Genomics have an API?

No public API is recorded for Eurofins Genomics.

What industry is Eurofins Genomics in?

Eurofins Genomics's product category is Genomics Services and DNA/RNA Synthesis. Its primary akta.pro industry code is HLAGAIAF, Molecular Biology & Genomics Instruments (PCR/qPCR, Sequencing, Microarrays), with a secondary code of HLAGAGAC, mRNA & Nucleic Acid Manufacturing Services (mRNA/saRNA/Plasmid DNA). Its NAICS code is 541714 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PrtimesDNA Synthesizer Market Size to Reach USD 6.71 Billion by 2032 as Synthetic Biology Scales – PR TimesThe global DNA Synthesizer Market is projected to grow from USD 4.21 billion in 2024 to USD 6.71 billion by 2032, reflecting a compound annual growth rate of 6%, driven by expanding applications in synthetic biology, genomics, personalized medicine, and biopharmaceutical R&D. North America held the leading market position in 2024, supported by strong biotechnology infrastructure and early technology adoption, while solid-phase synthesis remained the dominant technology segment. Key market participants including Thermo Fisher Scientific, Agilent Technologies, Integrated DNA Technologies, Eurofins Genomics, GenScript, Bioneer Corporation, and DNA Script are actively expanding capabilities through new product launches, automated services, and funding rounds to capture growth in gene editing, diagnostics, vaccine development, and emerging applications such as DNA data storage.PR NewswireEurofins Genomics US Launches Express Oxford Nanopore Sequencing Service with Same-Day ResultsEurofins Genomics US has launched a new express Oxford Nanopore sequencing service offering same-day whole plasmid sequencing results from its facility in Louisville, Kentucky. The service requires no primers or library preparation, delivers single-base accuracy up to 99%, and accepts long constructs ranging from 2.5 to 300 kb. The company is leveraging its proximity to the UPS North America hub and Gen3 NGS technology to provide fast results at a fraction of the time and cost of conventional NGS methods.PR NewswireEurofins Genomics U.S. launches new SARS-CoV-2 plasmid DNA controls and increases its capacity to produce probes and primers, all of which being key components of SARS-CoV-2 RT-PCR testingEurofins Genomics U.S., together with its subsidiary BlueHeron Biotechnology, has launched a series of SARS-CoV-2 plasmid DNA controls for verifying the presence of the COVID-19 virus, intended for both research and diagnostic applications. The company has also ramped up production of qPCR probes and primers for commercial and molecular diagnostic companies, having already fulfilled demand for millions of COVID-19 test kits worldwide. All materials are produced under ISO 13485 and ISO 9001 quality standards, with plasmid controls shipping within one day and qPCR assay panels within three days.PR NewswireEurofins Genomics US Expands Gene Synthesis Capabilities with Acquisition of Blue Heron BiotechEurofins Genomics has completed the acquisition of Blue Heron Biotech to expand its gene synthesis capabilities. The deal combines Eurofins' oligonucleotide and sequencing strengths with Blue Heron's expertise in complex gene constructs, strengthening their joint position in the synthetic biology market.PR NewswireThe global next-generation sequencing (NGS) services market size is expected to reach USD 2.87 billion by 2025 at a 13.6% CAGR during the forecast periodAccording to a Grand View Research report, the global next-generation sequencing (NGS) services market is projected to reach USD 2.87 billion by 2025, growing at a 13.6% CAGR, driven by technological advancements that have improved reproducibility and reduced costs for gene sequencing. Human genome sequencing services currently hold the largest revenue share, while gene regulation services such as small RNA sequencing and ChIP-seq are anticipated to grow at a lucrative pace. North America dominated the market by revenue in 2017 due to higher technology penetration and funding availability, with key players including Illumina, Eurofins Genomics, BGI, and GENEWIZ.PR NewswireEurofins Genomics US Announces Commercial Launch of Next Generation DNA Synthesis ServiceEurofins Genomics announced the U.S. commercial launch of its next-generation DNA synthesis service, offering scientists the ability to purchase precise quantities of high-quality oligonucleotides rather than excess material. The platform allows scalability from 0.5 nanomoles to very large orders, with same-day synthesis and overnight shipping available in the U.S. and Canada at no additional charge. The service is designed to reduce costs for researchers in molecular biology and synthetic biology while maintaining quality and turnaround times.PR NewswireEurofins Genomics Launches EXTREmers - Extremely Long OligonucleotidesEurofins Genomics announced the U.S. launch of EXTREmer oligonucleotides, a new product line featuring extremely long DNA sequences developed using high-fidelity synthesis chemistry on its proprietary platform. These oligos are designed to improve success rates and reduce timelines for applications such as synthetic biology and next-generation sequencing by enabling the construction of genes with low sequence variability.PR NewswireEurofins Genomics Receives Accreditation from CLIA and CAP for New Laboratory in LouisvilleEurofins Genomics has received accreditation from the College of American Pathologists (CAP) and certification under the Clinical Laboratory Improvement Amendments (CLIA) for its new laboratory in Louisville, Kentucky, where the company recently relocated its North American headquarters. The newly accredited facility will provide Sanger sequencing services for clinical laboratories requiring CLIA and CAP regulatory compliance. This accreditation demonstrates the laboratory meets federal and internationally recognized quality standards for testing human specimens for health assessment and disease diagnosis.PR NewswireEurofins Genomics Looks to Disrupt DNA Synthesis Market with Smaller-Scale, High-Throughput Service Featuring Rapid Turnaround and Lower PriceEurofins Genomics announced the launch of a limited beta program for a new DNA synthesis service designed to provide scientists with small quantities of high-quality oligonucleotides at reduced costs. The service utilizes a next-generation DNA synthesizer developed with aerospace engineers, producing yields between 0.5 and 4 nanomoles at lower prices compared to traditional high-throughput methods. The company plans to officially launch the service in early 2017 with next-day delivery capabilities, having recently relocated its North American headquarters to Louisville, Kentucky.